Schicha H - Search Results

1

Long-term follow-up of antithyroid peroxidase antibodies in patients with chronic autoimmune thyroiditis (Hashimoto's thyroiditis) treated with levothyroxine.

Schmidt M, Voell M, Rahlff I, Dietlein M, Kobe C, Faust M, Schicha H. Schmidt M, et al. Among authors: schicha h. Thyroid. 2008 Jul;18(7):755-60. doi: 10.1089/thy.2008.0008. Thyroid. 2008. PMID: 18631004

2

Incidence of postradioiodine immunogenic hyperthyroidism/Graves' disease in relation to a temporary increase in thyrotropin receptor antibodies after radioiodine therapy for autonomous thyroid disease.

Schmidt M, Gorbauch E, Dietlein M, Faust M, Stützer H, Eschner W, Theissen P, Schicha H. Schmidt M, et al. Among authors: schicha h. Thyroid. 2006 Mar;16(3):281-8. doi: 10.1089/thy.2006.16.281. Thyroid. 2006. PMID: 16571091

3

False-positive uptake of I-131 in a laryngocele mimicking thyroid remnant after thyroidectomy for papillary thyroid carcinoma.

Schmidt M, Dietlein M, Schröder U, Schicha H. Schmidt M, et al. Among authors: schicha h. Clin Nucl Med. 2006 Nov;31(11):716-7. doi: 10.1097/01.rlu.0000242696.68765.b6. Clin Nucl Med. 2006. PMID: 17053394

4

Radioiodine therapy for thyroid volume reduction of large goitres.

Bachmann J, Kobe C, Bor S, Rahlff I, Dietlein M, Schicha H, Schmidt M. Bachmann J, et al. Among authors: schicha h. Nucl Med Commun. 2009 Jun;30(6):466-71. doi: 10.1097/MNM.0b013e32832b5ccc. Nucl Med Commun. 2009. PMID: 19381116

5

Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?

Kobe C, Eschner W, Wild M, Rahlff I, Sudbrock F, Schmidt M, Dietlein M, Schicha H. Kobe C, et al. Among authors: schicha h. Nucl Med Commun. 2010 Mar;31(3):201-5. doi: 10.1097/MNM.0b013e328333d303. Nucl Med Commun. 2010. PMID: 19907353

6

Development of hypothyroidism during long-term follow-up of patients with toxic nodular goitre after radioiodine therapy.

Kahraman D, Keller C, Schneider C, Eschner W, Sudbrock F, Schmidt M, Schicha H, Dietlein M, Kobe C. Kahraman D, et al. Among authors: schicha h. Clin Endocrinol (Oxf). 2012 Feb;76(2):297-303. doi: 10.1111/j.1365-2265.2011.04204.x. Clin Endocrinol (Oxf). 2012. PMID: 21854403

7

Differentiation between healthy thyroid remnants and tumor tissue after radioiodine therapy in patients with differentiated thyroid carcinoma using in vitro phosphorus-31 magnetic resonance spectroscopy.

Moka D, Dietlein M, Raffelt K, Hahn J, Schicha H. Moka D, et al. Among authors: schicha h. Am J Med. 2002 Jun 1;112(8):634-41. doi: 10.1016/s0002-9343(02)01116-6. Am J Med. 2002. PMID: 12034413

8

Amiodarone-induced thyrotoxicosis due to destructive thyroiditis: therapeutic recommendations.

Dietlein M, Schicha H. Dietlein M, et al. Among authors: schicha h. Exp Clin Endocrinol Diabetes. 2005 Mar;113(3):145-51. doi: 10.1055/s-2005-837524. Exp Clin Endocrinol Diabetes. 2005. PMID: 15789273

9

Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit?

Dietlein M, Moka D, Reinholz U, Schmidt M, Schomäcker K, Schicha H, Wellner U. Dietlein M, et al. Among authors: schicha h. Nuklearmedizin. 2007;46(3):77-84. Nuklearmedizin. 2007. PMID: 17549318 Clinical Trial.

10

Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?

Kobe C, Eschner W, Sudbrock F, Weber I, Marx K, Dietlein M, Schicha H. Kobe C, et al. Among authors: schicha h. Nuklearmedizin. 2008;47(1):13-7. Nuklearmedizin. 2008. PMID: 18278207

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

374 results

Search Page

Filters